Literature DB >> 22240542

Vaccination of oncology patients: an effective tool and an opportunity not to be missed.

Camille N Kotton1, Mark C Poznansky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22240542      PMCID： PMC3267807          DOI： 10.1634/theoncologist.2011-0383

Source DB:  PubMed          Journal:  Oncologist        ISSN： 1083-7159


× No keyword cloud information.
  12 in total

1.  Repeated vaccination is required to optimize seroprotection against H1N1 in the immunocompromised host.

Authors:  Hugues de Lavallade; Paula Garland; Takuya Sekine; Katja Hoschler; David Marin; Kate Stringaris; Eva Loucaides; Katherine Howe; Richard Szydlo; Ed Kanfer; Donald Macdonald; Peter Kelleher; Nichola Cooper; Ahmad Khoder; Ian H Gabriel; Dragana Milojkovic; Jiri Pavlu; John M Goldman; Jane F Apperley; Katayoun Rezvani
Journal:  Haematologica       Date:  2010-10-22       Impact factor: 9.941

2.  Low influenza vaccination rate among patients receiving chemotherapy for cancer.

Authors:  P Loulergue; O Mir; J Alexandre; S Ropert; F Goldwasser; O Launay
Journal:  Ann Oncol       Date:  2008-07-28       Impact factor: 32.976

3.  Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

Authors:  Anthony E Fiore; David K Shay; Karen Broder; John K Iskander; Timothy M Uyeki; Gina Mootrey; Joseph S Bresee; Nancy J Cox
Journal:  MMWR Recomm Rep       Date:  2009-07-31

4.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

5.  Guidance on novel influenza A/H1N1 in solid organ transplant recipients.

Authors:  D Kumar; M I Morris; C N Kotton; S A Fischer; M G Michaels; U Allen; E A Blumberg; M Green; A Humar; M G Ison
Journal:  Am J Transplant       Date:  2009-12-02       Impact factor: 8.086

6.  Pandemic H1N1 influenza infection in adult transplant recipients.

Authors:  Isaac I Bogoch; Jason R Andrews; Elizabeth L Hohmann; Camille N Kotton; Francisco M Marty
Journal:  Transplantation       Date:  2011-06-27       Impact factor: 4.939

Review 7.  Utility of influenza vaccination for oncology patients.

Authors:  Daniel A Pollyea; Janice M Y Brown; Sandra J Horning
Journal:  J Clin Oncol       Date:  2010-04-12       Impact factor: 44.544

8.  Immunogenicity of an inactivated monovalent 2009 influenza A (H1N1) vaccine in patients who have cancer.

Authors:  Yiqing Xu; Nanda Methuku; Praveena Coimbatore; Theresa Fitzgerald; Yiwu Huang; Ying-Yi Xiao; Murali Pagala; Shachi Gupta; William Solomon; Philip Rubin; John Treanor; Alan Astrow; Howard Minkoff; Jay S Cooper
Journal:  Oncologist       Date:  2012-01-12

9.  Evaluation of pandemic H1N1 (2009) influenza vaccine in adults with solid tumor and hematological malignancies on active systemic treatment.

Authors:  Helen J Mackay; Jacob McGee; Diego Villa; Jonathan B Gubbay; Lisa M Tinker; Lily Shi; John Kuruvilla; Lisa Wang; Katrina MacAlpine; Amit M Oza
Journal:  J Clin Virol       Date:  2010-12-17       Impact factor: 3.168

10.  Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients.

Authors:  Markus Bickel; Nils von Hentig; Imke Wieters; Pavel Khaykin; Gabi Nisius; Annette Haberl; Christoph Stephan; Eva Herrmann; Hans W Doerr; Hans Reinhard Brodt; Regina Allwinn
Journal:  Clin Infect Dis       Date:  2011-01-01       Impact factor: 9.079
View more
  5 in total

Review 1.  Practical review of immunizations in adult patients with cancer.

Authors:  Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Hum Vaccin Immunother       Date:  2015-06-25       Impact factor: 3.452

Review 2.  Challenges in the Role of Gammaglobulin Replacement Therapy and Vaccination Strategies for Hematological Malignancy.

Authors:  Silvia Sánchez-Ramón; Fatima Dhalla; Helen Chapel
Journal:  Front Immunol       Date:  2016-08-22       Impact factor: 7.561

Review 3.  Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia.

Authors:  Alessandro Allegra; Alessandro Tonacci; Caterina Musolino; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Front Immunol       Date:  2021-10-25       Impact factor: 7.561

Review 4.  Monoclonal Gammopathy of Undetermined Significance (MGUS)-Not So Asymptomatic after All.

Authors:  Oliver C Lomas; Tarek H Mouhieddine; Sabrin Tahri; Irene M Ghobrial
Journal:  Cancers (Basel)       Date:  2020-06-12       Impact factor: 6.639

5.  Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial.

Authors:  Peter Vink; Ignacio Delgado Mingorance; Constanza Maximiano Alonso; Belen Rubio-Viqueira; Kyung Hae Jung; Juan Francisco Rodriguez Moreno; Enrique Grande; David Marrupe Gonzalez; Sarah Lowndes; Javier Puente; Hartmut Kristeleit; David Farrugia; Shelly A McNeil; Laura Campora; Emmanuel Di Paolo; Mohamed El Idrissi; Olivier Godeaux; Marta López-Fauqued; Bruno Salaun; Thomas C Heineman; Lidia Oostvogels
Journal:  Cancer       Date:  2019-02-01       Impact factor: 6.860
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.